Archive

The SDG Tent is the place to put the Davos conversation into context with the on-the-ground reality faced by leaders, sparking real-world impact.

DSM announces global price increases for all its Arnite® PBT & PET, Arnitel® copolyester elastomers, Stanyl® polyamide 4,6, Akulon® and Novamid® polyamide 6,6 products

Royal DSM and FC Basel 1893 announce new partnership in nutrition and health, with DSM committed to the promotion of top level football in the Basel (CH) region as new FCB Premium Partner.

New culture developed to create the highly specific taste and texture of the Castellano-type cheese.

Two major product launches that will help accelerate adoption of 3D printing into mainstream production.

Together, the companies will produce highly sought-after, sweet-tasting molecules, such as steviol glycosides Reb M and Reb D through fermentation, giving food and beverage manufacturers an even more scalable, sustainable and low cost-in-use solution than if these same molecules were extracted from the stevia leaf.

Baril Coatings has become the latest industry player to adopt the Decovery® plant-based resin for a new generation of sustainable paints that will benefit consumer health while helping to safeguard the planet.

New culture meets consumer demand for premium yogurts which offer all the health and nutrition they expect with an indulgent, creamy taste for a special treat.

Combination of DSM’s high-performance AM grades with e-Xstream’s accurate printing process simulation solution identifies manufacturing issues before printing using DSM 3D printing thermoplastic grades.

Sale of Fibrant’s caprolactam business to Highsun completed with DSM anticipating receiving about €200 million in cash related to this transaction, which is expected to be received in various steps in 2018 and 2019.

Attendees from national and international companies, NGOs, universities and other forward-thinking organizations were joined at this year’s summit by world leaders from the public and private sectors, an opportunity for participants of all ages to make lasting connections to drive positive change.

New plant serves as catalyst for growth in India, reinforcing DSM’s strong ambitions for the country.

Ertharin Cousin, former Executive Director of the United Nations World Food Programme, has joined DSM's Sustainability Advisory Board.

DSM awarded the Top Green Companies in Asia Award at the 2018 Asia Corporate Excellence & Sustainability (ACES) Awards.

Hybrane CY235 enables enhanced coatings performance, higher throughput and reduced energy consumption.

DSM has extended its partnership with the World Food Programme by 3 years to continue fighting hidden hunger and enabling better nutrition for vulnerable people.

DSM repurchased 209,327 shares from 1st to 5th October 2018 at an average price of €90.13, thereby concluding the program to repurchase 1,100,000 shares for a total consideration of €98.9 million.

On 27 September 2018 DSM organized a lunch discussion in the New York Public Library on the role of purpose-led business in addressing the SDGs and creating value for society.

DSM repurchased 121,592 shares from 24th up to and including 28th September 2018 at an average price of €91.88.

DSM's production capacity of its sustainable liquid polyester technology and other specialty resins expanded with new polyester production facility in Meppen, Germany.

North American price of Uralac® range of polyester powder coating resins will increase for all formulations effective 1 October 2018, or as contracts allow.

With DSM’s Akulon® RePurposed the resin used is fully recycled from discarded nylon-based fishing nets and is known for its sustainability profile as much as its performance.

DSM repurchased 69,638 shares from 17th up to and including 21st September 2018 at an average price of €91.24.

On 19 September DSM’s CEO was invited to represent the private sector at the G7 Ministerial Meeting on Working Together on Climate Change, Oceans, and Clean Energy.

Novamid® ID1030 CF10 3D is designed for 3D printing stronger, stiffer and tougher structural parts.

DSM repurchased 94,032 shares from 10th up to and including 14th September 2018 at an average price of €88.38.

Formfutura will distribute DSM's high performance additive manufacturing filaments to customers in the fast-growing additive manufacturing/3D printing industry.

Price increase due to the manufacturing industry experiencing a continuous rise in overall cost of input materials and a strong increase in end-use demand.

DSM recognized among the DJSI leaders for 15 years running and held the number one position in the sector eight times.

Balancius™ is the first and only microbial muramidase that works in the intestine to improve feed efficiency and increase sustainable product yield.

DSM repurchased 189,309 shares from 3rd up to and including 7th September 2018 at an average price of €88.16.

New report indicates consumers are still largely unaware of acrylamide, but those who do know something know enough to be concerned.

DSM repurchased 117,471 shares from 27th up to and including 31st August 2018 at an average price of €91.17.

On 8 September 2018, The Ocean Cleanup is launching the world’s first system to rid the oceans of plastic and DSM is there in support.

DSM repurchased 82,975 shares from 20th up to and including 24th August 2018 at an average price of €89.58.

DSM made Fortune Magazine’s 2018 Change the World list and Sustainalytics also recognized DSM when it named the company the leader in ESG (environmental, social and governance) within the chemicals industry for the second year in a row.

DSM invites you to discover the evolving role of vitamins and lipids in pharmaceutical applications at CPhI Worldwide 2018.

DSM to open the industry’s only premix manufacturing facility built exclusively for the maternal and infant nutrition market.

DSM repurchased 215,656 shares from 13th up to and including 17th August 2018 at an average price of €89.80.

Silfab incorporating DSM's recently launched conductive backsheet capable of increasing module efficiency into its highest-efficiency PV solar modules.

Starting 13 August 2018 DSM intends to repurchase in total 1,100,000 ordinary shares: 500,000 ordinary shares to cover commitments under share-based compensation plans and 600,000 ordinary shares to cover commitments for stock dividend as part of the interim dividend 2018.

DSM pursues patent infringement law suit for misappropriation of intellectual property pertaining to the production of a key ingredient of Biotin (also known as Vitamin B7 or Vitamin H).

DSM announces price increases for Arnite® PBT and PET products effective 1 September 2018 or as contracts allow.

Promising technology platform to potentially deliver therapies to treat a broad spectrum of ophthalmic diseases.

The re-granulates, generated from multilayer PE/PA6 packaging waste can be used again in demanding flexible packaging which contributes to the target of a circular economy.

AVANSYA™ is DSM’s new brand for sustainably produced, non-artificial sweeteners that answer to the need for advanced, flexible sugar reduction in a wide range of foods and beverages

DSM introduces PreventASe® XR, an enzymatic solution that prevents the formation of acrylamide in high-pH applications such as corn chips, biscuits, and crackers.

Concentrated recovery: DSM’s Fruitflow® to power athletes in grueling Tour de France 2018.

DSM aims to give the coating industry a greater insight into the bright science and application expertise driving new levels of performance in coatings.

Investment builds on the previously announced partnership between DSM and Mixfit and combines DSM’s unparalleled expertise in essential micronutrients with the technological edge of Mixfit to analyze health data in real-time, address nutritional gaps in an effective way and supporting a healthy lifestyle.

BakeZyme® AAA enables bakeries to reduce ascorbic acid in their recipes while maintaining the ideal bread texture and volume.

Bain Capital intends to acquire DSM Sinochem Pharmaceuticals, a DSM and Sinochem Group 50/50 joint venture, with the transaction expected to be completed in the fourth quarter of 2018 subject to customary regulatory approvals and consultations.

DSM's Uralac® and Uranox® range of Can and Coil coating resins manufactured in Europe will, depending on product, increase by 0.05 - 0.12 €/kg for shipments from 1 July 2018 or as contracts allow.

North American prices for DSM’s Uralac® polyester powder coating resins will increase by $0.03-$0.06 USD/pound ($0.07-$0.14 USD/kg) for all formulations effective beginning 1 July 2018, or as contracts allow.

DSM repurchased 324,894 shares from 15th up to and including 20th June 2018 at an average price of €88.18, thereby concluding the program to repurchase 1,600,000 shares for a total consideration of €136.7 million.

DSM announces price increases for all Akulon® and Novamid® PA66 compound products, effective 15 July 2018, or as contracts allow.

Prices for DSM's Uralac® range of polyester powder coating resins prices will, depending on product, increase by 0.08 - 0.12 €/kg for shipments for EMEA as from 20 June 2018 or as contracts allow.

With its unique science-based competences, DSM is ideally positioned to capture the growth opportunities offered by the global megatrends and Sustainable Development Goals (SDGs), with a particular focus on Nutrition & Health, Climate & Energy and Resources & Circularity.

DSM repurchased 132,098 shares from 8th up to and including 14th June 2018 at an average price of €89.07.

Report, which surveyed 3,300 consumers in seven countries in the Europe and US, shows that 4 in 5 craft beer drinkers don’t believe craft beer is a passing fad and some 80% said they would continue trying new brands of beer.

eBOOST™ provides consistent increased ethanol yield while significantly reducing glycerol production.

Accelerzyme® CPG, DSM's proprietary enzyme for accelerated cheese ripening, is now benzoate-free.

DSM repurchased 141,033 shares from 1st up to and including 7th June 2018 at an average price of €88.22.

Website marks a significant step for this technology: a unique family of plant-based paint resins that deliver sustainability benefits with no compromise on performance.

From 2018 all DSM's purchased electricity in the Netherlands will come from renewable sources, thanks to an agreement with Dutch energy supplier Eneco.

Vepa, a leader in project furniture design and DSM collaborate to further demonstrate the value of powder coating technology as an operationally convenient and sustainable alternative to solvent-based liquid coating technology for heat-sensitive substrates.

DSM showcases innovative new prebiotic, vitamin, enzyme, texture, taste, coloration and sugar reduction solutions in its portfolio.

DSM repurchased 233,975 shares from 25 up to and including 31 May 2018 at an average price of €86.30.

ISO PRO+ energy beverage with optimal muscle recovery benefits contains DSM’s Peptopro® to aid faster protein absorption and support immediate muscle recovery, both during and after exercise.

AIF’s plant in Kigali has an annual production capacity of 45,000 tons making it one of the largest nutrition factory sites on the continent and it works with over 9,000 farmers across Rwanda and produces meals for 1.5 million people every day.

DSM has linked the interest rate of new €1 billion Revolving Credit Facility to its performance on the reduction of GHG emissions.

DSM repurchased 176,500 shares from 18 up to and including 24 May 2018 at an average price of €88.02.

New technology ushers in a new era of lossless conductivity in high-power modules thanks to an efficient design that connects neighboring cells to transport more power from the module.

DSM and CVC Capital Partners indirectly own 35% and 65% respectively of the shares of Fibrant BV through Chemicalnvest joint venture.

DSM repurchased 91,500 shares from 14 up to and including 17 May 2018 at an average price of €87.39.

A Federal Court in Wisconsin concluding that all glycerol reducing ethanol yeast products sold by Lallemand infringe DSM’s US Patent.

Strong demand for both Dyneema UD (Uni-Directional laminate) and Dyneema fiber prompts increase.

DSM declares a dividend for the financial year 2017 of €1.85 per ordinary share.

DSM held its Annual General Meeting of Shareholders on 9 May 2018. Shareholders approved all resolutions on the agenda.

Summary of the resolutions and voting at DSM's Annual General Meeting of Shareholders 2018.

Royal DSM issues its full Q1 2018 results, which are in line with the preliminary figures for Q1 2018 previously announced on 12 April 2018.

Facility will have prolonged shutdown in 2nd half of 2018 to implement an extensive series of upgrades; DSM assures security of supply of vitamin C to contracted customers during shutdown.

DSM further expands its portfolio, now offering the broadest selection of 3D printing materials for the broadest range of printing technologies.

Giving customers more choices speeds 3D printing’s move into real manufacturing.

New proprietary Uralac® one shot matte powder coating HAA system delivers better reproducibility and enables lower crosslinker levels and curing temperatures than current alternatives.

Fortune says it assessed leaders on wealth creation rather than size as conventionally measured and credits Sijbesma’s focus on sustainability and notably his work in carbon pricing as key reasons for his inclusion.

DSM to showcase latest innovations in high-performance engineering thermoplastics and Dyneema®, the world’s strongest fiber™.

New forum will convene private sector leaders around competitiveness concerns that could inhibit the worldwide uptake of carbon pricing.

Companies develop custom-made and 3D mouthguards printed on-the-spot to protect teeth and mouth injuries in any type of sport that involves bats, balls, sticks or person-to-person contact.

DSM repurchased 88,350 shares from 6 up to and including 12 April 2018 at an average price of €81.74.

Continued strong organic sales growth in underlying business estimated at 11%. Adjusted EBITDA growth of underlying business estimated at 7% despite significant FX headwind. Additional temporary vitamin price benefit estimated at €165m on Adjusted EBITDA. Overall very strong quarter with total Adjusted EBITDA up 55%.

DSM to showcase ideas for easing stress on consumers and formulators and detailing its strategy for meeting the societal challenges of skin cancer at this year’s in-cosmetics Global trade show.

DSM repurchased 87,000 shares from 3 up to and including 5 April 2018 at an average price of €80.10.

DSM repurchased 188,000 shares from 23 March up to and including 29 March 2018 at an average price of €79.38.

DSM introduces Delvo®ADD, a portfolio of adjunct cultures for creating unique, aged cheddar cheese taste profiles.

DSM committed to bringing innovative solutions to the biofuels industry with a full portfolio offering of yeast and enzymes for starch, fiber and biomass conversions.

DSM showcases capabilities in personalized nutrition, while visitors can experience new scientifically-proven, consumer-tested delivery formats.

DSM repurchased 136,650 shares from 19 March up to and including 22 March 2018 at an average price of €80.59.

Strategic partnership to deliver personalized nutrition solutions, providing individuals with the nutrients they need for optimal health based on a comprehensive set of health and activity measurements.

New Uralac® Ultra website marks new chapter for this breakthrough technology, which enables first-time-right powder coating of heat-sensitive substrates such as medium-density fiberboard (MDF).

PPG Wood Finishes, Weekamp Deuren and DSM collaborate to further develop sustainable exterior doors by using recycled wood and plant-based coating.

Companies signed two long-term power purchase agreements (PPAs) that enabled construction of two windfarm projects.

DSM intends to repurchase 500,000 ordinary shares, starting on 19 March 2018, in order to cover commitments under share based compensation plans and 1,100,000 ordinary shares, starting on 14 May 2018, in order to cover commitments for stock dividend as part of the final dividend 2017.

Maxilact® Smart enables a significant increase in production efficiency and capacity, allowing dairy producers to meet the growing demand for lactose-free dairy products.

DSM will be demonstrating PENTAVITIN®, a skin hydration solution dedicated to supporting skin in urban contexts.

The 2017 Integrated Annual Report details the company's progress and performance over the year in terms of People, Planet and Profit.

Successful Initial Determination in DSM Desotech’s International Trade Commission case against Momentive UV Coatings (Shanghai) Co., Ltd. and OFS Fitel, LLC.

Prices of epoxy-containing can and coil coating resins will, depending on product, increase by 0.30 - 0.35 €/kg for shipments as from 1 March or as contracts allow.

DSM highlights its range of ingredients and solutions for the dairy industry.

DSM Engineering Plastics to increase prices globally for several polyamide and thermoplastic polyester products, effective 1 April or as contracts allow.

BIOMILK 300 is a compact residual lactose-analyzing device offering dairy producers a fast, cost-effective, and accurate analyzer for quantifying residual lactose levels in lactose-free and lactose-reduced dairy products

DSM again reports an excellent year, as it significantly exceeded its Strategy 2018 targets for EBITDA, ROCE and organic sales growth.

First part of a new report in DSM's Global Insight Series is focused on breakfast habits and behavior in Europe and the US.

Fédéric Boned, formerly VP Global Sales DSM Personal Care, appointed EMEA Vice President (VP) of DSM Nutritional Products Human Nutrition & Health as of 1 January 2018.

After a second challenge before the Boards of Appeal of the European Patent Office, the key patent behind game-changing Dyneema® Force Multiplier Technology is upheld."

Latest addition to DSM's coating resins portfolio, Rubbert Skins®, Silky Skins® and Vel-Veeto Skins®, create a world of feel opportunities for food and non-food packaging whether on coated or uncoated paper, board, plastics and even aluminum.

Wilfrid Gambade appointed as President DSM Dyneema as of 15 January 2018.

Gareth Barker appointed President DSM Personal Care & Aroma Ingredients as of 1 January 2018.

Sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris’s high-volume products finalized.

DSM expands its offering in gut health ingredients with probiotics, an attractive market segment in nutritional ingredients, growing an estimated 7% per year.

Prices for Uralac® range of polyester powder coating resins will increase by $0.04-$0.06 USD/pound ($0.09-$0.14 USD/kg) for all formulations effective from 15 Januay 2018, or as contracts allow.

Collaboration to focus on developing fully recyclable and healthier alternatives for particleboard, MDF and other panel materials which can be used in industries such as building & construction, furniture, interior decoration and displays.

Feike Sijbesma reflects on progress on carbon pricing as DSM joined heads of government and public and private finance at the One Planet Summit in Paris.

Call for framework conditions laying foundation for a pathway to limiting global temperature rise to well below 2° Celsius and allow them to actively contribute to the implementation of the Paris Agreement.

Akulon® and Novamid® polyamide 6 unfilled polymer grades EMEA prices increase effective immediately.

Report details how four major corporate renewable energy buyers came together to successfully aggregate demand and jointly sign multiple wind power PPAs in Europe.

DSM Venturing closes investment rounds in LECT and NOMADD, DSM Advanced Solar enters a joint development agreement with SunSniffer; and SunDensity’s material is being tested at Fraunhofer CSE.

New materials will provide a cost-effective solution in applications exposed to humidity and high temperatures, including automotive connectors, control devices, and sensors.

Cultures allow cheesemakers to create healthier continental cheeses using low-fat milk with the same taste and texture that consumers expect from a full-fat product.

DSM in process of expanding capacity of its specialty polymers plants in Emmen and Geleen, the Netherlands in response to strong customer demand in high temperature polyamides (PAs) and thermoplastic copolyesters (TPC).

First taste modulator of its kind that is natural, allergen-free, clean label, and can be used in a wide variety of applications from savory soups and sauces to sweet beverages and desserts.

DSM reinforces its position in the can and coil coatings segment and ensures it remains fit for growth in the BPA-free market.

Auping is the first non-carpet company that will use the Niaga® technology to develop fully recyclable mattresses and the collaboration will give complementary insights to this redesign challenge.

DSM and Amyris enhance their strategic alliance through the sale of Amyris Brasil Ltda to DSM and the establishment of a long-term manufacturing partnership for Amyris’ high-volume products.

DSM repurchased 151,900 shares from 10 November to 14 November 2017 at an average price of €75.63, concluding the program to repurchase 1,600,000 shares for a total consideration of €109.3 million.

DSM positioned to outpace its global target of 50% purchased electricity from renewable sources by 2025.

New organization builds on sector expertise and collaboration.

DSM and Haixing will be able to expand their global business of sustainable and innovative hydrocolloid solutions applied in food, beverage and personal care products to provide texture and stability.

DSM repurchased 243,624 shares from 3 November up to and including 9 November 2017 at an average price of €76.15.

Novel braiding technology of DSM’s Dyneema Purity® fibers available by means of a patented platform technology entitled “IMPLANTABLE HOLDING DEVICE” developed by partner, Meister & Cie AG.

Modified PA46 Stanyl® HGR2 as used in chain tensioner arms on F-150 and Mustang helped the Ford Motor Company win a 2017 SPE Automotive Innovation Award.

Agreement involves all DSM businesses supplying materials and technology to the automotive sector - Engineering Plastics, Dyneema®, and 3D Printing including Somos® for stereolithography(SLA), and other technologies like Fused Filament Fabrication (FFF).

DSM Dyneema demonstrates potential to turn used soft armor vests into creative new products.

Delvo®Cheese SW-250 developed specifically for the efficient manufacture of mature, firm-textured Emmental-type cheeses.

DSM highlights range of nutritional and functional ingredients that contribute to health and wellness at this year’s Food Ingredients Europe, with a special spotlight on better breakfasts at home and on-the-go.

Strong performance in Q3 2017, contributing to very good first nine months.

Arnitel was selected for the soft strap on the ZTE Smart Watch, providing comfort, flexibility, safety and design flexibility. Arnitel also feels cool and smooth on the skin, with a good balance of physical and chemical properties.

Partnership to focus on reaching mothers and children with nutrition interventions during the crucial first 1,000 days of children’s lives, from conception to age 2.

Stanyl plant in Geleen obtains almost 85% of its purchased electricity from renewables whilst the site in Pune, India, now meets 50% of its total electricity requirements from renewable sources.

DSM to showcase portfolio of nutritional ingredients, high performance coloration solutions, customized premixes and food specialty ingredients at this year’s Gulfood Manufacturing.

With ForTii Ace DSM brings a new level of technology to the OPE industry with a material that remains stable at very high temperatures.

DSM adds glass-reinforced grade of its ground-breaking high temperature-resistant ForTii Ace polyamide and Xytron polyphene sulphide (PPS) compounds to its specialty portfolio of materials for products used in water management.

Report focuses on consumer attitudes and behavior around the labelling of sugar content.

The World Resources Institute honored DSM CEO Feike Sijbesma at its 2017 Courage to Lead dinner in New York City, recognizing his bold leadership to solve global challenges.

Strategic partnership aligns DSM’s regenerative materials capabilities with proprietary synthetic small peptide (P-15) technology developed by Cerapedics.

DSM announces agreement between Somos® and RP America for the distribution of Somos 3D printing materials in the US market."

DSM has increased capacity for production of UV curable coatings for its fiber optic materials business with the addition of the DSM-AGI Taiwan facility, allowing the business to meet increased customer demand and provide a local supply chain for the Asia market.

DSM repurchased 37,600 shares from 6 October up to and including 12 October 2017 at an average price of €69.54.

Connecting Bright Innovations 2017’ Innovation Partnering Conference saw eight promising start-ups pitch to a panel of expert venturing and innovation specialists at the event, which focused on new and innovative products and biotechnologies for food, health and (bio)tech applications.

DSM repurchased 140,692 shares from 29 September up to and including 5 October 2017 at an average price of €69.52.

Prices for Uralac® range of polyester powder coating resins will increase by $0.05-$0.07 USD/pound ($0.11-$0.15 USD/kg) for all formulations effective from 15 October 2017, or as contracts allow.

Collaboration between Somos and 3D Hubs provides an online service for customers to obtain accurate 3D printed tooling or molds with quick turn-around time using Somos PerFORM.

PPG launches a new bio-based wall paint for the professional - and consumer market; Sigma Air Pure. The new paint is based on DSM’s revolutionary Decovery® bio-based technology.

On 27 September 2017 a fatal accident took place at DSM's site in Augusta (GA, US), in which a contractor sadly lost his life and two others injured, and expected to recover.

DSM repurchased 163,310 shares from 22 September up to and including 28 September 2017 at an average price of €67.75.

DSM’s partnership with non-profit service organization the Musculoskeletal Transplant Foundation to distribute biologic products for use in plastic and reconstructive surgery, addressing the changing needs of hospitals and providers by offering a full suite of biologic products.

DSM partners with Mahle to replace metal end caps with high-heat-resistant plastics in charge air cooler (CAC) applications, leading to improved engine performance, better fuel efficiency and reduced system costs.

EBITDA and ROCE outlook for 2017 confirmed. DSM aims to continue to deliver against its strategic targets in 2018. DSM brings forward its regular strategic review process for the period beyond 2018 and expects to share the conclusions before the summer of 2018.

DSM repurchased 117,424 shares from 15 September up to and including 21 September 2017 at an average price of €66.56.

Twilmij’s core values, customer portfolio and solutions are a perfect fit with DSM’s ambitions in the animal nutrition & health market.

Conditional approval of an Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA) allows Actamax to begin a pivotal clinical trial to evaluate the safety and efficacy of Actamax Adhesion Barrier.

DSM repurchased 128,851 shares from 8 September up to and including 14 September 2017 at an average price of €66.04.

DSM will increase prices for Fortitech® Premixes by an average 10% with immediate effect. Existing contracts & commitments will not be affected.

DSM in 2nd place in Fortune Magazine’s 3rd annual Change the World list, which recognizes 56 companies that have had a positive social impact through activities that are part of their core business strategy.

DSM repurchased 142,315 shares from 1 September up to and including 7 September 2017 at an average price of €65.01.

DSM again named among worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index having been named among the global leaders for the past 14 years and holding the number one position in the sector seven times, including last year.

DSM introduces material solution for high-pressure composite tanks for hydrogen storage to help reduce CO2 emissions.

DSM repurchased 188,430 shares from 25 August up to and including 31 August 2017 at an average price of €64.01.

Thermo Fisher Scientific Inc. has completed the acquisition of Patheon N.V. (NYSE:PTHN), a company in which DSM held approximately 48.7 million ordinary shares.

DSM to showcase new therapeutic concepts featuring active pharmaceutical ingredients (APIs), particularly vitamins and lipids for pharmaceutical applications, at CPhI.

DSM repurchased 185,837 shares from 18 August 2017 up to and including 24 August 2017 at an average price of €63.98.

DSM repurchased 100,017 shares in the period from 14 August 2017 up to and including 17 August 2017 at an average price of €63.21.

DSM intends to repurchase 1,600,000 ordinary shares, starting on 14 August 2017, in order to cover its commitments under existing management and personnel option plans (1,200,000) and shares for stock dividend as part of the interim dividend 2017 (400,000).

DSM has concluded acquisition of the outstanding shares in its DSM-AGI joint venture gaining sole ownership of the Taiwan-based supplier of innovative, high-quality and environmentally friendly UV-curable resins and other specialty chemicals.

DSM maintained its positive momentum with a very strong first half-year performance with Q2 another very good quarter.

Research collaboration agreement includes option to license DSM's bioerodible polymer implant technology for evaluating its application to the delivery of certain Aerie compounds, initially focused on retinal diseases.

DSM secures European Union regulatory approval to market first and only enzyme, Tolerase® G, demonstrated to effectively break down residual gluten.

Patrick Niels is appointed as President of DSM Food Specialties as of 1 August 2017.

Helen Mets will join DSM as per 1 August 2017 in the role of President DSM Resins & Functional Materials.

Judith Wiese will join DSM as Executive Vice President Group People & Organization on 1 October 2017.

Addition of PARSOL® Max and PARSOL® Shield makes DSM’s portfolio of UV filters the broadest in the Personal Care industry.

DSM repurchased 261,898 shares from 7 July to 13 July 2017 at an average price of €63.24, concluding the program to repurchase 2,900,000 shares for a total consideration of €187.2 million.

DSM repurchased 218,403 shares from 30 June up to and including 6 July 2017 at an average price of €63.72.

DSM repurchased 182,175 shares from 23 June up to and including 29 June 2017 at an average price of €65.07.

Four early-stage companies with innovative solutions to reduce the levelized cost of electricity for photovoltaic (PV) systems.

DSM first plastics producer in the world to offer materials that meet the highest flame resistance requirements of standards organizations all around the world and which also have the required electrical properties.

DSM repurchased 122,307 shares from 16 June up to and including 22 June 2017 at an average price of €67.16.

Prices for Uralac® and Uranox® range of liquid coating resins for Can and Coil supplied from Europe will, depending on product, increase by 0.10 - 0.15 €/kg for shipments as from 1 July 2017 or as contracts allow.

DSM repurchased 123,435 shares from 9 June up to and including 15 June 2017 at an average price of €66.00.

Production facility for omega-3 fatty acids from natural marine algae for initial use in salmon aquaculture and pet food expected to come on stream in 2019.

DSM’s new range, specifically formulated for gluten-free applications, will help producers win customers and fans in this fast-growing market segment by improving the softness and moistness of their offerings.

Support from DSM and global partners to scale-up 100% renewable energy solution.

Prices for Uralac® range of polyester powder coating resins will, depending on product, increase by 0.10 - 0.20 €/kg for shipments as from 1 July 2017 or as contracts allow

Chinese camera maker YI Technology has chosen Arnitel high performance thermoplastic elastomer for the hand grip on its new camera, the M1.

DSM repurchased 132,717 shares from 2 June up to and including 8 June 2017 at an average price of €65.73.

Companies collaborate to create an advanced materials protective cover with optimized features for sea, air and land-mobile systems.

Report confirms Delvotest T is a reliable, robust and easy to use test eminently suitable for detecting antimicrobial drug residues in milk.

DSM increasing price for Akulon® and Novamid® polyamide 6 unfilled polymer grades by $0.07/lb in North America and $154/ton in South America effective 15 June 2017 where contracts allow.

DSM repurchased 123,673 shares from 26 May up to and including 1 June 2017 at an average price of €66.16.

AIF Rwanda now producing highly nutritious porridge flours (with added milk, vitamins and minerals) targeting vulnerable population segments such as pregnant and breast-feeding mothers, older infants and young children in the first 1,000 days of their lives.

DSM repurchased 123,847 shares from 19 May up to and including 25 May 2017 at an average price of €66.10.

DSM repurchased 139,447 shares from 12 May up to and including 18 May 2017 at an average price of €66.66.

Thermo Fisher will commence a tender offer to acquire all of the issued and outstanding shares of Patheon for $35.00 per ordinary share in cash.

DSM repurchased 128,958 shares from 5 May up to and including 11 May 2017 at an average price of €65.76.

Liquid coating resins prices increase by 0.05 to 0.36 €/kg in EMEA & by 0.02 to 0.23 $/lb in North America depending on the product, effective 1 June 2017 or as contracts allow.

Innovation is desperately needed to keep soldiers and law enforcement personnel protected from ever-evolving threats, while lightening their load to enable them to perform their duties effectively.

Findings from across Europe reveal that supplement intake peaked during pregnancy and very early motherhood.

DSM to make equity investment in Amyris and the companies to enter development cooperation focused on products for the health and nutrition markets.

DSM repurchased 114,048 shares from 28 April up to and including 4 May 2017 at an average price of €66.44.

DSM declares a dividend for the financial year 2016 of €1.75 per ordinary share.

DSM held its Annual General Meeting of Shareholders on 3 May 2017. Shareholders approved all resolutions on the agenda.

Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2017.

DSM reports a very strong first quarter in 2017.

DSM repurchased 126,540 shares from 21 April up to and including 27 April 2017 at an average price of €65.81.

DSM’s latest skin active, BEAUACTIVE®, addresses concerns about conspicuously enlarged pores and areas of darker pigmentation known as age spots, which are exacerbated by sunlight.

Conference will focus on new and innovative products and (bio)technologies that enable better food for everyone.

In the coming year Feike Sijbesma will chair the CPLC together with co-chair Catherine McKenna, Minister of Environment & Climate Change (Canada).

DSM repurchased 75,948 shares from 18 April up to and including 20 April 2017 at an average price of €65.02.

ET Solar will apply DSM’s new high-durability backsheets to boost power gain in their high-efficiency modules.

DSM’s new Anti-Soiling coating for PV solar glass provides a unique combination of anti-soiling and anti-reflective properties, and is aimed specifically at PV modules in dry, desert-like climates, boosting their Internal Rate of Return (IRR).

DSM repurchased 126,073 shares from 7 April up to and including 13 April 2017 at an average price of €65.16.

Finalists selected from ten best science and entrepreneurial team submissions.

DSM repurchased 134,338 shares from 31 March up to and including 6 April 2017 at an average price of €64.04.

DSM and paint manufacturer ICA Group jointly develop new, sustainable paint - Iridea Bio - containing DSM’s Decovery® plant-based resin.

New state-of-the-art biotechnology facility will accelerate DSM’s biotechnology research and development capabilities for applications in food and nutrition, feed, fuel, pharma and bio-based materials.

North American prices pf Uralac® polyester powder coating resins will, increase by $0.10-0.20 USD/pound with additional surcharges for super durable formulations, effective for shipments from 15 April 15 2017, or as contracts allow.

DSM repurchased 235,605 shares from 24 March up to and including 30 March 2017 at an average price of €62.81.

DSM repurchased 308,025 shares from 17 March up to and including 23 March 2017 at an average price of €62.12.

DSM proposes re-appointment of Dimitri de Vreeze the Managing Board and appointment of John Ramsay and Frits van Paasschen to the Supervisory Board.

Somos® Taurus is the first SLA material to be both durable and have the ability to withstand elevated temperatures.

DSM repurchased 222,563 shares from 13 March up to and including 16 March 2017 at an average price of €62.92 for a total of €14.0 million.

Prices of Uralac® polyester powder coating resins in EMEA will increase by 0.15 - 0.45 €/kg and Uralac® and Uranox® liquid coating resins supplied from Europe will increase by 0.15 - 0.35 €/kg for shipments as from 1 April 2017 or as contracts allow.

DSM will be presenting its commitment to sustainability at this year’s in-cosmetics trade show and demonstrating how its Bright Science enables customers to create magical products with an emotional appeal.

DSM to repurchase 2,900,000 ordinary shares starting 13 March 2017 to cover commitments under existing management and personnel option plans and shares for stock dividend as part of final dividend 2016.

Company to highlight growing portfolio of high-performance composites, including Dyneema® Carbon and Dyneema flexible composites, along with a range of thermoplastic unidirectional (UD) tapes, and Somos® 3D printing materials.

DSM has expanded its range of natural food protection solutions with the launch of a new range of highly effective protective cultures that increase the shelf life of dairy products such as yogurt, sour cream and fresh cheese.

Cutting edge Dyneema Purity® Black fiber addresses previously unmet need among surgeons for strongly contrasting material to simplify complex suture procedures.

2016 Integrated Annual Report, in which DSM reports on its progress and performance over the year in terms of People, Planet and Profit, published on 3 March 2017.

DSM driving force behind SunRISE TechBridge Challenge II, building on the success of the first SunRISE TechBridge Challenge.

Recent study proves long-term ballistic performance of Dyneema® soft ballistic personal protection equipment.

Ruling once again demonstrates strength of DSM Dyneema’s Intellectual Property portfolio and innovations and confirms it as an innovator in the field of high strength fibers and ballistic resistant material solutions.

DSM submits Investigational Device Exemption to FDA to study the Actamax™ Adhesion Barrier in a prospective, randomized controlled trial in gynecological laparoscopic surgery.

The increases will take effect for all orders shipped on or after 16 March 2017, or follow as contracts allow.

Plant has achieved 70 gallon per ton conversion rate and POET-DSM Advanced Biofuels will now build an on-site enzyme manufacturing facility in Emmetsburg, Iowa, pending state and local approvals.

DSM acquires Sunshine (Suzhou SunShine New Materials Technology Co., Ltd.) - manufacturer of a novel, high-performance solar photovoltaic (PV) backsheet based on co-extrusion technology.

SunRISE TechBridge Challenge II seeks solutions to increase performance of solar PV systems, resulting in a lower levelized cost of energy and broader deployment of affordable PV.

Agreement sealed to provide SIT students with industry experience as part of a holistic learning approach.

DSM reports a very good 2016 in which it achieved strong EBITDA and ROCE growth, well ahead of the mid-term targets set out in its Strategy 2018: Driving Profitable Growth.

DSM updates way its financial results are presented starting with Q4/full-year results for 2016, following recent changes to accounting and reporting guidelines in Europe.

DSM presents new “5 Actives - 5 Actions” approach to improving skin resilience against environmental stressors. Visitors can also experience high-SPF sun care with a light, pleasant skin feel.

North American prices of Uralac® polyester powder coating resins will increase by $0.04 USD/pound ($0.09 USD/kg) for standard durable formulations, and by $0.06 USD/pound ($0.13 USD/kg) for super durable formulations effective for shipments from 1 March 2017.

Price of Akulon® compounds increases by 250 €/T in Europe with immediate effect.

Robin Chase, cofounder and former CEO of Zipcar, member of Boards of Veniam, World Resources Institute and Tucows and advisor to French National Digital Agency and USDOT’s Advisory Committee on Automated Transportation, joins DSM's Sustainability Advisory Board.

Akulon® and Novamid® polyamide 6 unfilled polymer grades prices increase by €250/ton in Europe, $0.12/lb in North America and $250/ton in South America effective 30 January 2017 or where contracts allow.

Feike Sijbesma, Kofi Annan and Christiana Figueres to act as Climate Leaders in supporting The World Bank Climate Action Plan.

Prices for Uralac® range of polyester powder coating resins will, depending on product, increase by 0.05 - 0.12 €/kg for shipments as from 15 January 2017 or as contracts allow.

DSM repurchased 361,907 of its own shares from 2 December 2016 up to and including 8 December 2016 at an average price of €56.21 and concluded the program to repurchase 1,700,000 shares.

DSM repurchased 215,424 of its own shares from 25 November 2016 up to and including 1 December 2016 at an average price of €57.32.

DSM repurchased 248,036 of its own shares from 18 November 2016 up to and including 24 November 2016 at an average price of €57.14.

DSM announces the departure of Managing Board and Executive Committee member Stephan B. Tanda as of 1 February 2017.

DSM repurchased 360,149 of its own shares from 11 November 2016 up to and including 17 November 2016 at an average price of €56.21.

DSM reports another strong quarter in Q3 2016.

DSM repurchased 514,484 of its own shares from 4 November 2016 up to and including 10 November 2016 at an average price of €56.17.

DSM intends to repurchase up to 1,700,000 ordinary shares, starting on 4 November 2016, in order to cover its commitments under existing management and personnel option plans.

DSM announces the successful launch of a €750 million bond, with a ten-year maturity due in 2026, at a coupon of 0.75%.

DSM has been named the worldwide leader in the Materials industry group in the Dow Jones Sustainability World Index 2016.

DSM reports a second consecutive strong quarter in 2016.

DSM announces the successful completion of its secondary offering of 4,761,905 ordinary shares in Patheon N.V. in connection with Patheon N.V.’s Initial Public Offering of ordinary shares.

DSM repurchased 83,073 of its own shares from 15 July 2016 up to and including 21 July 2016 at an average price of €56.75 and concluded the program to repurchase 3,500,000 shares.

Patheon N.V., a company in which DSM holds approximately 53.5 million ordinary shares, has priced its Initial Public Offering at USD 21.00 per ordinary share.

DSM repurchased 107,432 of its own shares from 8 July 2016 up to and including 14 July 2016 at an average price of €54.67.

Patheon N.V., a company in which DSM holds approximately 53.5 million ordinary shares, has today commenced an Initial Public Offering.

DSM repurchased 95,055 of its own shares from 1 July 2016 up to and including 7 July 2016 at an average price of €52.09.

DSM repurchased 248,553 of its own shares from 24 June 2016 up to and including 30 June 2016 at an average price of €50.64.

DSM repurchased 115,202 of its own shares from 17 June 2016 up to and including 23 June 2016 at an average price of €53.57.

DSM repurchased 125,684 of its own shares from 10 June 2016 up to and including 16 June 2016 at an average price of €53.20.

DSM intends to increase the running share repurchase program as announced on 22 February 2016 by an additional 300,000 ordinary shares to a total of 3,500,000 ordinary shares to cover the interim stock dividend 2016.

DSM repurchased 151,361 of its own shares from 27 May 2016 up to and including 2 June 2016 at an average price of €54.46.

DSM repurchased 152,420 of its own shares from 20 May 2016 up to and including 26 May 2016 at an average price of €53.26

DSM repurchased 152,511 of its own shares from 13 May 2016 up to and including 19 May 2016 at an average price of €52.54.

DSM repurchased 153,360 of its own shares from 6 May 2016 up to and including 12 May 2016 at an average price of €52.27.

DSM repurchased 153,694 of its own shares from 29 April 2016 up to and including 5 May 2016 at an average price of €52.34.

DSM provides an update on the development of its Nutrition organization and several key positions to further support its growth plans.

DSM held its Annual General Meeting of Shareholders on 29 April 2016. Shareholders approved all resolutions on the agenda.

Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2016.

DSM repurchased 163,523 of its own shares from 22 April 2016 up to and including 28 April 2016 at an average price of €53.25.

DSM declares a dividend for the financial year 2015 of €1.65 per ordinary share of €1.50 nominal value.

DSM reports a strong first quarter in 2016.

DSM repurchased 153,579 of its own shares from 15 April 2016 up to and including 21 April 2016 at an average price of €52.05.

DSM repurchased 153,992 of its own shares from 8 April 2016 up to and including 14 April 2016 at an average price of €50.01.

DSM repurchased 167,229 of its own shares from 1 April 2016 up to and including 7 April 2016 at an average price of €47.8951.

DSM repurchased 93,033 of its own shares from 29 March 2016 up to and including 31 March 2016 at an average price of €48.5712.

All members of the Executive Committee purchase ordinary shares in Royal DSM, expressing their confidence in the growth prospects of the company.

DSM repurchased 159,637 of its own shares from 18 March 2016 up to and including 24 March 2016 at an average price of €48.28.

DSM repurchased 161,667 of its own shares from 11 March 2016 up to and including 17 March 2016 at an average price of €48.06.

DSM repurchased 232,331 of its own shares from 4 March 2016 up to and including 10 March 2016 at an average price of €47.13.

DSM repurchased 269,930 of its own shares from 26 February 2016 up to and including 3 March 2016 at an average price of €45.84.

DSM announces the publication of its 2015 Integrated Annual Report.

DSM repurchased 267,680 of its own shares from 22 February 2016 up to and including 25 February 2016 at an average price of €43.94.

Ndidi Okonkwo Nwuneli, founder of LEAP Africa and co-founder of AACE Food Processing & Distribution Ltd and partner at Sahel Capital, an advisory and private equity firm, has joined DSM's Sustainability Advisory Board.

DSM to repurchase 3,200,000 ordinary shares in order to cover its commitments under existing management and personnel option plans and shares for stock dividend as part of the final dividend 2015.

Q4 Group net sales up 6% to €1,926m and EBITDA up 3% to €261m.

At the Annual General Meeting of Shareholders the Supervisory Board will nominate Mr. Pradeep Pant for appointment as a member of DSM's Supervisory Board.

DSM and the United Nations World Food Programme sign agreement extending their existing partnership to combat hidden hunger and malnutrition in the developing world to 2018.

DSM and Syngenta R&D partnership to develop microbial-based agricultural solutions, including bio-controls, bio-pesticides and bio-stimulants.

After a period of transformation, DSM will focus on improving its financial results through organic growth, reducing costs and strict capital allocation.

Sales up 8%, driven by 7% organic growth in Nutrition and foreign exchange.

DSM awarded FD-Henri Sijthoff prize for the best annual report by a company listed on the AEX stock exchange in the Netherlands for its 2014 Integrated Annual Report.

DSM successfully issued a €500 million 1.375% bond due 2022.

DSM named among the worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index 2015.

Adjustments to organizational and operating model aim to create more agile, focused and cost efficient organization, with a stronger business and market focus and globally leveraged support functions.

Solid sales performance with a 12% increase to €1,965 million, supported by foreign exchange rates and 3% volume growth.

Partnership finalized for DSM’s activities in Polymer Intermediates (Caprolactam & Acrylonitrile) and Composite Resins with formation of ChemicaInvest B.V..

DSM repurchased 204,254 of its own shares from 24 July 2015 up to and including 28 July 2015 at an average price of €52.44 and concluded the program to repurchase 2,300,000 shares.

DSM repurchased 184,648 of its own shares from 17 July 2015 up to and including 23 July 2015 at an average price of €54.52.

DSM repurchased 74,088 of its own shares from 10 July 2015 up to and including 16 July 2015 at an average price of €53.54.

DSM repurchased 190,870 of its own shares from 3 July 2015 up to and including 9 July 2015 at an average price of €51.34.

DSM repurchased 362,143 of its own shares from 26 June 2015 up to and including 2 July 2015 at an average price of €53.03.

DSM repurchased 245,123 of its own shares from 19 June 2015 up to and including 25 June 2015 at an average price of €53.87.

DSM begins debate on the contribution of science to society: www.sciencecanchangetheworld.org.

DSM repurchased 223,561 of its own shares from 12 June 2015 up to and including 18 June 2015 at an average price of €52.87.

DSM repurchased 185,315 of its own shares from 5 June 2015 up to and including 11 June 2015 at an average price of €53.36.

DSM repurchased 277,686 of its own shares from 29 May 2015 up to and including 4 June 2015 at an average price of €53.95.

DSM repurchased 128,219 of its own shares from 22 May 2015 up to and including 28 May 2015 at an average price of €53.8102.

DSM repurchased 224,093 of its own shares from 18 May 2015 up to and including 21 May 2015 at an average price of €53.18.

DSM intends repurchasing 2,300,000 ordinary shares, starting on 18 May 2015, in order to cover its commitments under existing management and personnel option plans.

DSM declares dividend for the financial year 2014 of €1.65 per ordinary share.

DSM held its Annual General Meeting of Shareholders on 30 April 2015. Shareholders approved all resolutions on the agenda.

Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2015.

Sales of €1,886 million, up 11%, including 2% organic sales growth.

DSM Synres produced solvent-borne alkyd and acrylic coating resins for the global coatings, adhesives and graphic arts markets.

Figures reflect reclassification of Polymer Intermediates cluster and DSM Composite Resins to discontinued operations. Corporate Activities are restated and also reflect the sale of DSM Synres.

DSM has successfully issued a €500 million 1.0% bond due 2025.

DSM finalizes acquisition of Aland, a Hong Kong-based company producing vitamin C in mainland China.

DSM proposes re-appointment of Stephan B. Tanda and announces departure of Stefan Doboczky as of 1 June 2015.

Partnership for DSM’s activities in Polymer Intermediates (Caprolactam and Acrylonitrile) and Composite Resins with formation of new company 65% owned by CVC and 35% by DSM.

Euroresins, a distributor of products to the composite resins industry, sold to Cathay Investments.

DSM announces publication of 2014 Integrated Annual Report.

Sales of €9,181 million, a 4% increase versus 2013. In line with market expectations, DSM reported EBITDA of €1,168 million compared to €1,261 million in 2013.

DSM has reached agreement with Cathay Investments for the sale of Euroresins and the transaction is expected to close in Q1 2015.

DSM has reached agreement with Standard Investment for the sale of DSM Synres and the transaction is expected to close in Q1 2015.

DSM provides investors with update on its strategic progress and current priorities at annual Capital Markets Day.

Third quarter 2014 EBITDA from continuing operations of €315 million compared to €293 million in Q2 2014 and €331 million in Q3 2013.

DSM named among the worldwide leaders in the Materials industry group in the Dow Jones Sustainability World Index 2014.

POET-DSM Advanced Biofuels proves its revolutionary technology that converts agricultural residue into renewable fuel at opening of its first commercial cellulosic ethanol plant.

DSM's second quarter 2014 EBITDA from continuing operations of €293 million compared to €332 million in Q2 2013, and €272 million in Q1 2014.

DSM reaches agreement to acquire Aland, a Hong Kong-based company producing vitamin C in mainland China.

Production of a few intermediates, mainly for Animal Nutrition & Health interrupted. Impact on customers expected to be minimal.

DSM repurchased 69,522 of its own shares from 16 May 2014 up to and including 19 May 2014 at an average price of €51.67 and concluded the program to repurchase 5,000,000 shares.

DSM repurchased 176,832 of its own shares from 9 May 2014 up to and including 15 May 2014 at an average price of €51.97.

DSM repurchased 294,921 of its own shares from 2 May 2014 up to and including 8 May 2014 at an average price of €52.03.

DSM declares dividend for the financial year 2013 of €1.65 per ordinary share.

DSM held its Annual General Meeting of Shareholders on 7 May 2014. Shareholders approved all resolutions on the agenda.

Summary of the resolutions at DSM'S Annual General Meeting of Shareholders 2014.

DSM reports first quarter EBITDA from continuing operations of €272 million compared to €301 million in Q1 2013.

DSM repurchased 201,426 of its own shares from 25 April 2014 up to and including 30 April 2014 at an average price of €51.49.

DSM repurchased 170,120 of its own shares from 22 April 2014 up to and including 24 April 2014 at an average price of €50.42.

DSM repurchased 231,586 of its own shares from 11 April 2014 up to and including 17 April 2014 at an average price of €49.15.

DSM repurchased 256,801 of its own shares from 4 April 2014 up to and including 10 April 2014 at an average price of €50.17.

DSM in exclusive discussions with Aland that may or may not result in the acquisition of this China-based global producer of vitamin C.

DSM repurchased 149,321 of its own shares from 28 March 2014 up to and including 3 April 2014 at an average price of €50.05.

DSM repurchased 157,579 of its own shares from 21 March 2014 up to and including 27 March 2014 at an average price of €48.46.

DSM repurchased 108,500 of its own shares from 14 March 2014 up to and including 20 March 2014 at an average price of €46.51.

DSM repurchased 254,756 of its own shares from 7 March 2014 up to and including 13 March 2014 at an average price of €47.40.

USD 2.65 billion transaction to create global CDMO leader successfully completed.

DSM to appoint Geraldine Matchett as Member of the Managing Board of Directors as of 1 August 2014 and as of 1 December 2014, she will become Chief Financial Officer.

DSM repurchased 428,636 of its own shares from 27 February 2014 up to and including 6 March 2014 at an average price of €46.54.

DSM issues €500 million 2.375% bond due 2024.

DSM intends to repurchase 2,500,000 ordinary shares starting on 27 February 2014 to cover its commitments under existing management and personnel option plans.

For full year 2013 DSM delivered 18% higher EBITDA while facing challenging economic environment. In Q4 the company realized 30% higher EBITDA.

DSM repurchased 874,725 shares from 17 January 2014 up to and including 21 January 2014 at an average price of €51.85 and concludes first part of program to repurchase 4-5 million shares in total.

DSM delivered roughly 20% higher EBITDA for the full year 2013, in spite of the challenging economic environment and in Q4 realized an approximately 30% higher EBITDA.

DSM repurchased 245,742 shares from 10 January 2014 up to and including 16 January 2014 at an average price of €56.90.

DSM repurchased 112,588 shares from 6 January 2014 up to and including 9 January 2014 at an average price of €57.88.

DSM repurchased 154,586 shares from 13 December 2013 up to and including 19 December 2013 at an average price of €55.35.

Final Terms of the €300,000,000 1.75% Notes due 13 November 2019 adjusted to reflect investors have a put option in the event of a change of control.

DSM repurchased 185,761 shares from 6 December 2013 up to and including 12 December 2013 at an average price of €56.08.

DSM repurchased 164,545 shares from 29 November 2013 up to and including 5 December 2013 at an average price of €57.17.

Award recognizes DSM's global corporate leadership in efforts to mitigate food insecurity, prevent hidden hunger and promote sustainable development in low-income countries.

DSM repurchased 198,288 shares from 22 November 2013 up to and including 28 November 2013 at an average price of €58.39.

DSM repurchased 346.038 shares from 15 November 2013 up to and including 21 November 2013 at an average price of €59.06.

Global CDMO company combines DSM Pharmaceutical Products and Patheon.

DSM repurchased 217,727 shares from 6 November 2013 up to and including 14 November 2013 at an average price of €58.05.

DSM successfully issues €300 million 1.75% bond due 2019.

DSM intends to repurchase 2,500,000 ordinary shares starting on 6 November 2013 in order to cover its commitments under existing management and personnel option plans.

Q3 EBITDA of €342 million compared to €270 million in Q3 2012. 27% improvement realized despite ongoing challenging macro-economic environment.

DSM acquires 19% equity interest in Yantai Andre Pectin Co. Ltd., a China based producer of texturing ingredients.

DSM providing review of strategic progress and update on its 2015 targets at its annual Capital Markets Day.

DSM once again amongst leaders in chemical industry sector in Dow Jones Sustainability World Index 2013.

DSM reports second quarter EBITDA of €345 million compared to €290 million in Q2 2012 and €311 million in Q1 2013.

DSM acquires Unitech Industries Limited, a New Zealand based producer of nutritional products for both human and animal markets.

Feike Sijbesma joins Global CEO Council (GCC) of the Chinese People’s Association for Friendship with Foreign Countries (CPAFFC).

DSM to help provide effective nutrition interventions to 50 million pregnant and lactating woman and children under two per year by 2020 as part of DSM’s endorsement of Global Nutrition for Growth Compact.

Working together to achieve lasting progress in global health and development by improving the nutritional status of mothers and children.

Agreement to acquire 19% equity interest in Yantai Andre Pectin Co. Ltd. (Andre Pectin), a China based producer of texturing ingredients.

DSM declares a dividend for the financial year 2012 of €1.50 per ordinary share of €1.50 nominal value.

DSM held its Annual General Meeting of Shareholders on 3 May 2013. Shareholders approved all resolutions on the agenda.

Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2013.

DSM reports first quarter EBITDA of €311 million compared to €306 million in Q1 2012 and €243 million in Q4 2012.

Strategic partnership with Rostekhnologii (Rostec) in fields of biotechnology and functional materials.

Partnership with Ministry of Health Care of the Republic of Tatarstan aims to modernize the Republic’s public health sector through fortified nutrition.

DSM acquires Tortuga, a nutritional supplements company with a focus on pasture raised beef and dairy cattle for a total enterprise value of about €440 million.

DSM proposes appointing Mr. Dimitri de Vreeze to the Managing Board effective 1 September 2013.

DSM sells its participation in DEXPlastomers, a 50/50 Joint Venture of DSM with affiliate of ExxonMobil Chemical, to Borealis.

DSM delivered growth across all clusters in 2012 excluding caprolactam. Nutrition represents more than 70% of total EBITDA and become high value, global business with attractive growth prospects across the full value chain.

Agreement extends existing partnership to 2015 to combat hidden hunger and malnutrition in the developing world.

Completing acquisition of Fortitech is another milestone in implementation of DSM’s Nutrition strategy.

Award recognizes DSM's integrated Triple P approach to creating a sustainable business and shared value with all stakeholders.

University of Maastricht confers honor on Feike Sijbesma because of way he embodies DSM’s core value, sustainability.

Acquisition enables DSM to become a global tier one dairy ingredients supplier.

DSM awarded Sustainable Supply Chain Award 2012 for its responsible way of managing its supply chain.

DSM receives three prestigious awards in the Netherlands for its 2011 Integrated Annual Report.

Agreement with Borealis AG reached for sale of DEXPlastomers V.o.F and DSM's LldPE Compact Solution Technology.

Definitive agreement to acquire Fortitech, Inc. (Fortitech) in an all cash transaction for a total enterprise value of $634 million.

DSM continues to generate good results mainly driven by Nutrition cluster and make good progress towards strategic goals with purchase of Tortuga and Cargill’s cultures and enzymes business.

DSM to acquire Cargill’s cultures and enzymes business in an all cash transaction for a total enterprise value of €85 million.

DSM updates financial community at its annual Capital Markets Days on progress made with its DSM in Motion: driving focused growth strategy.

Chris Goppelsroeder appointed President and CEO DSM Nutritional Products effective 1 January 2013.

DSM in exclusive discussions with Cargill which may, or may not result in DSM's acquisition of Cargill’s cultures and enzymes business.

DSM again among leaders in chemical industry sector in the Dow Jones Sustainability World Index 2012.

Definitive agreement to acquire Tortuga Companhia Zootécnica Agrária (Tortuga) in all cash transaction for total enterprise value of about €465 million.

Life Sciences cluster accounts for around 70% of Q2 EBITDA offsetting weakness caused by caprolactam in Materials Sciences. Other Materials Sciences businesses improve.

DSM acquires Ocean Nutrition Canada, leading global provider of fish-oil derived nutritional products to dietary supplement and food and beverage markets for a total enterprise value of C$540 million.

DSM completes acquisition of Kensey Nash for a total enterprise value of approximately $360 million.

Tender offer to purchase all outstanding shares of common stock of Kensey Nash Corporation at a price of $38.50 per share successful.

Expiration of mandatory waiting period under Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for previously announced tender offer for all outstanding shares of common stock of Kensey Nash Corporation.

DSM qualified as supplier of enzymes for DONG Energy - Inbicon’s wheat straw to cellulosic ethanol process.

DSM commences previously announced tender offer for all outstanding shares of common stock of Kensey Nash at a price of $38.50 per share.

Definitive agreement with Clearwater Fine Foods and funds managed by Richardson Capital to acquire Ocean Nutrition Canada for a total enterprise value of C$540 million.

Annual General Meeting of Shareholders approves appointing Mrs. Victoria Haynes and Mrs. Eileen Kennedy as Supervisory Board members.

DSM declares a dividend for 2011 of €1.45 per ordinary share of €1.50 par value.

DSM held its Annual General Meeting of Shareholders on 11 May 2012. Shareholders approved all resolutions on the agenda.

Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2012.

In a challenging business environment, DSM continued to make good progress in Q1 and the robust results represent a positive start to 2012.

DSM will acquire all outstanding shares of common stock of Kensey Nash through a cash tender offer, followed by a merger with a subsidiary of DSM, for $38.50 in cash per share for total enterprise value of approximately $360 million.

Jos Op Heij new Senior Vice President Corporate Control and Accounting, Hans Vossen new VP Corporate Treasury & Dave Huizing new VP Investor Relations.

DSM acquires certain assets, licenses and other agreements in the area of food enzymes and oilseed processing from Verenium for a total consideration including transaction and related expenses of $37 million.

2011 was another strong year for DSM despite challenges of global economy, adverse currency movements and high raw material costs and increases dividend for second consecutive year.

Cees Los joins DSM as General Counsel and Director Legal Affairs as of 15 April 2012.

Joint Venture to commercially demonstrate and license cellulosic bio-ethanol, the next step in the development of biofuels, based on their proprietary and complementary technologies.

DSM Supervisory Board proposes appointing Mrs. Victoria Haynes and Mrs. Eileen Kennedy as Supervisory Board members.

Q3 2011 EBITDA from continuing operations €339 million, 26% ahead of Q3 2010, outlook remains unchanged: 2011 is expected to be a strong year with further progress towards achieving 2013 targets.

DSM repurchased 502,990 shares from 27 October 2011 up to and including 2 November 2011 at an average price of €37.33 and concluded the program to repurchase 4,000,000 shares.

DSM repurchased 471,588 shares from 20 October 2011 up to and including 26 October 2011 at an average price of €36.81.

TCG has developed and patented the OtCM™ system which measures and monitors patient therapy compliance while interacting wirelessly with home diagnostic devices to correlate compliance with drug therapy.

DSM repurchased 545,760 shares from 13 October 2011 up to and including 19 October 2011 at an average price of €37.15.

DSM repurchased 391,817 shares from 6 October 2011 up to and including 12 October 2011 at an average price of €35.51.

DSM has repurchased 519,526 shares from 29 September up to and including 5 October 2011 at an average price of €32.42.

DSM acquires Shandong ICD High Performance Fiber Co. Ltd. (ICD), based in Laiwu, Shandong province, China.

DSM updates investment community on progress made with strategy marking the shift from an era of intensive portfolio transformation to a strategy for the coming years of maximizing sustainable and profitable growth of ‘the new DSM’.

DSM repurchased 523,199 shares from 22 September 2011 up to and including 28 September 2011 at an average price of €31.49.

Unsecured credit facility of €500 million is for a minumum term of 5 years and a maximum term of 7 years.

DSM has repurchased 404,055 shares from 15 September 2011 up to and including 21 September 2011 at an average price of €32.52.

On 13 September 2011 a fatal accident took place on DSM property in Augusta (Georgia, USA), in which one contractor lost his life. DSM deeply regrets this tragic accident and expresses its sympathy to the victim’s family.

DSM has repurchased 641,065 shares from 7 September 2011 up to and including 14 September 2011 at an average price of €31.84.

DSM Personalized Nutrition’s corporate wellness business will become part of Viocare’s operations.

DSM once again retained its number one position in the chemical industry sector in the Dow Jones Sustainability World Index.

DSM intends to repurchase 4,000,000 ordinary shares, starting on 7 September 2011 in order to cover its commitments under existing management and personnel option plans.

Sinochem Group has taken a 50% equity interest in DSM Anti-Infectives for total cash consideration of €210 million on a cash and debt-free basis with 1 January 2011 as effective date.

Exchange ratio for the dividend in shares has been determined at 1 new ordinary share for every 72.338 existing ordinary shares.

Philip Eykerman will join DSM as Executive Vice President Corporate Strategy & Acquisitions.

Q2 EBITDA from continuing operations €339 million, above both Q2 2010 and Q1 2011.

DSM and Nutreco confirm they have decided to jointly explore the possibility to acquire Provimi.

DSM acquires 51% stake in AGI Corporation of Taiwan (AGI), a manufacturer of environmentally friendly UV (ultraviolet) curable resins and other products, through a subscription for newly to be issued shares combined with a public tender offer for about €41 million in total.

Two joint ventures of DSM Engineering Plastics and KA relate to marketing and sales of engineering plastics in Russia and other members of the Commonwealth of Independent States (CIS) and secondly for the production of engineering plastics compounds in a plant located in Togliatti (Russia).

Acquisition of Vitatene allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural products continues to grow.

Acquisition will allow DSM to combine C5 Yeast Company’s business with its own advanced yeast and enzyme technologies for second generation biofuels, further increasing its leadership position in this field.

Exchange ratio for the dividend in shares has been determined at 1 new ordinary share for every 48.077 existing ordinary shares.

DSM repurchased 264,319 shares from 13 May 2011 up to and including 16 May 2011 at an average price of €46.56 and concluded the program to repurchase 5,000,000 shares.

DSM has repurchased 502,059 shares from 6 May 2011 up to and including 12 May 2011 at an average price of €46.05.

Acquisition allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural products continues to grow.

DSM's CEO, Feike Sijbesma, received the prestigious George Washington Carver Award for Innovation in Industrial Biotechnology in recognition of his outstanding contribution and vision to the development and innovation in industrial biotechnology.

Companies to build a commercial scale plant for the production of bio-based succinic acid, the first non-fossil feedstock derived chemical building block that allows customers in the chemical industry to choose a bio-based alternative with a lower eco-footprint for a broad range of applications.

DSM repurchased 601,953 shares from 29 April 2011 up to and including 5 May 2011 at an average price of €45.78.

DSM completes sale of DSM Elastomers to LANXESS for €310 million on a cash and debt-free basis.

DSM has tendered its 4.95% stake in Danisco to DuPont.

DSM repurchased 435,987 shares from 26 April 2011 up to and including 28 April 2011 at an average price of €45.33.

DSM declares dividend for 2010 of €1.35 per ordinary share of €1.50 par value.

DSM held its Annual General Meeting of Shareholders on 28 April 2011. Shareholders approved all resolutions on the agenda.

Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2011.

Q1 EBITDA from continuing operations up 14% to €325 million.

DSM intends to appoint Mr. Atzo Nicolaï (1960), currently Member of the Dutch House of Representatives (“Tweede Kamer der Staten-Generaal”) with effect from 1 June 2011.

DSM repurchased 368,294 shares from 15 April 2011 up to and including 21 April 2011 at an average price of €42.70.

DSM repurchased 326,090 shares from 8 April 2011 up to and including 14 April 2011 at an average price of €43.53.

DSM repurchased 376,582 shares from 1 April 2011 up to and including 7 April 2011 at an average price of €43.97.

DSM will implement changes in the presentation of its financial results as from Q1 2011.

DSM repurchased 349,822 of its own shares from 25 March 2011 up to and including 31 March 2011 at an average price of €43.34.

DSM repurchased 331,532 of its own shares from 18 March 2011 up to and including 24 March 2011 at an average price of €42.33.

DSM repurchased 479,895 shares from 11 March 2011 up to and including 17 March 2011 at an average price of €41.13.

DSM repurchased 499,687 shares from 4 March 2011 up to and including 10 March at an average price of € 43.49.

DSM repurchased 463,780 shares from 24 February 2011 up to and including 3 March 2011 at an average price of €42.74.

Partnership with Kemrock Industries in India for the production of specialty composite resins in India.

Acquisition for a total consideration of about €790 million adds new growth platform for healthy and natural food ingredients for infant formula and other food and beverage applications, especially focused on PUFAs such as microbial Omega-3 DHA and Omega-6 ARA.

DSM successfully completes subsequent offering period to its all-cash tender offer to purchase all of the outstanding shares of common stock of Martek Biosciences Corporation at a price of $31.50 per share.

Jinling DSM Resins Co., Ltd. (JDR) will invest approximately €50 million in a new production facility for composite resins in Nanjing, China.

Supervisory Board proposes appointing Mr. Stefan Doboczky to DSM's Managing Board with effect from 1 May 2011.

Q4 operating profit from continuing operations up 17% to €170 million. Full-year operating profit from continuing operations up 74% to €752 million. Dividend increase of 12.5% to €1.35 per ordinary share proposed for 2010.

Royal DSM N.V today introduces a new company brand: Bright Science. Brighter Living™. The new brand is symbolic of the transition to the ‘new’ DSM.

DSM intends to repurchase 5,000,000 ordinary shares, starting on 24 February 2011, in order to cover its commitments under existing management and personnel option plans.

DSM Supervisory Board has appointed Rob Routs as its new Chairman.

Tender offer to purchase all of the outstanding shares of common stock of Martek Biosciences Corporation (NASDAQ: MATK), at a price of $31.50 per share, was successful.

Unconditional clearance of the Counsel of the National Competition Commission in Spain for tender offer for all outstanding shares of common stock of Martek Biosciences Corporation at a price of $31.50 per share.

DSM to acquire the majority shareholding in Shandong ICD High Performance Fibre Co Ltd. based in Laiwu, China.

DSM will use new P&L from the publication of the full year 2010 results onwards.

Expiration of the mandatory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, for DSM's offer for all outstanding shares of common stock of Martek Biosciences Corporation (NASDAQ: MATK) at a price of $31.50 per share.

DSM and United States Agency for International Development (USAID) to collaborate and collectively work to meet the nutritional challenges presented in the developing world.

DSM Engineering Plastics to enter two joint ventures with KA.

DSM commences tender offer for all outstanding shares of common stock of Martek Biosciences Corporation at a price of $31.50 per share.

DSM holds a 4.95% stake in Danisco which has been acquired some years ago.

DSM will acquire all the outstanding shares of common stock of Martek for $31.50 in cash per share for total consideration of $1,087 million.

As part of the joint venture agreement, Sinochem Group will take a 50% equity interest in DSM Anti-Infectives for a total cash consideration of €210 million on a cash and debt-free basis.

In accordance with applicable IFRS accounting standards – the remaining impairment of approximately €55 million for DSM Anti-Infectives will be reversed in Q4 2010.

DSM Special Products B.V. sold to Emerald Performance Materials.

DSM agrees sale of the remaining part of DSM Elastomers (DSM Elastomers) to LANXESS for €310 million on a cash and debt-free basis.

Comparative figures as result of divestment of Keltan, and finalized divestment of Thermoplastic Elastomers (Sarlink).

AGI offers a broad range of environmentally friendly UV (ultraviolet) curable resins and other products used in coatings for paper, wood, plastic and graphic arts applications.

DSM Supervisory Board proposes appointing Mrs. Pauline F.M. van der Meer Mohr as member of its Supervisory Board.

DSM continues its number one position in the chemical industry sector in the Dow Jones Sustainability World Index.

Q3 2010 operating profit from continuing operations up 28% to € 185 million (versus € 144 million in Q3 2009). Sales growth from continuing operations 19% compared to Q3 2009. Based on the continued positive business environment, 2010 is expected to be a strong year for DSM.

Comparative figures reflect the reclassification of Citric Acid from the Base Chemicals and Materials cluster to discontinued operations.

Actamax Surgical Materials LLC. to develop, manufacture and commercialize advanced surgical biomedical materials, pending European Union regulatory approval.

Ambitious new targets key elements of new strategy, building on Vision 2010, a phase of portfolio transformation.

Intended sale of Citrique Belge is a result of DSM’s ambitions to focus on Life Sciences and Materials Sciences.

DSM honored for its innovative and targeted solutions specifically designed to meet the nutritional requirements of those in the developing world.

Aquisition will allow DSM to incorporate Microbia’s proprietary platform and world class research and development capabilities and support DSM’s ongoing development of the natural carotenoids market.

Sale of Thermoplastic Elastomers (Sarlink®), part of the business group DSM Elastomers, to Teknor Apex agreed.

On Saturday 11 September 2010, a fatal accident took place at the site of DSM in Capua, in which three contractors tragically lost their lives.

Saturday 11 September 2010, a fatal accident took place at the site of DSM in Capua, in which three contractors tragically lost their lives.

DSM once again listed as one of the top leaders in the chemical industry sector in the Dow Jones Sustainability World Index.

Q2 operating profit from continuing operations €246 million (versus €85 million in Q2 2009 and €194 million in Q1 2010). Sales growth from continuing operations 28% compared to Q2 2009. Based on current positive business environment, 2010 is expected to be a strong year for DSM.

Comparative figures reflect the reclassification of DSM Special Products from the Base Chemicals and Materials cluster to discontinued operations.

Innovations will result in greatly improved process economics and productivity for second generation biofuel producers coupled with the sustainability benefits derived from the use of second generation feedstocks.

OCI will start integrating the businesses as of 1 June 2010.

DSM completes acquisition of Mitsubishi Chemical Corporation’s (MCC) Novamid® polyamide business in exchange for DSM’s Xantar® polycarbonate business.

Q1 operating profit from continuing operations €196 million (versus €44 million in Q1 2009 and €149 million in Q4 2009). Organic sales growth from continuing operations +25% compared to Q1 2009. 2010 is expected to be a good year for DSM.

Mrs. Louise Gunning-Schepers will step down as member of the DSM Supervisory Board with effect from 1 September 2010 in connection with her appointment as president of the Health Council of the Netherlands.

An interim dividend of €0.40 per ordinary share having been paid on 28 August 2009, the final dividend for 2009 will amount to €0.80 per ordinary share.

DSM held its Annual General Meeting of Shareholders on 31 March 2010. Shareholders approved all resolutions on the agenda.

Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2010.

Agreement for the sale of DSM Agro and DSM Melamine to OCI for €310 million on a cash and debt-free basis with effect from 1 January 2010.

Comparative figures reflect the reclassification of DSM Agro and DSM Melamine from the Base Chemicals and Materials cluster to discontinued operations.

DSM to acquire MCC’s Novamid® polyamide business in exchange for DSM’s Xantar® polycarbonate business.

DSM ends 2009 with solid Q4 and very strong cash generation. Full year operating profit from continuing operations €370 million. Full year cash flow from operating activities very strong at €1,276 million. Solid financial position − dividend maintained at €1.20 in cash.

DSM Supervisory Board proposes to appoint Mr. Rob Routs as a member.

Three year extension of global partnership with the World Food Programme (WFP).

DSM reinforces strong position in markets such as metal packaging (can), pre-painted metal (coil), specialty decorative markets, specialty adhesives, graphic arts and industrial wood.

Agreement to jointly develop a revolutionary coating resin using carbon dioxide as a raw material.

Shaw Industries and DSM Chemicals North America previously joint venture partners in NPC.

Joint venture agreement for the production, commercialization and market development of bio-based succinic acid, subject to regulatory approvals and notifications.

Feike Sijbesma receives prestigious 2010 Humanitarian of the Year Award from the United Nations Association of New York for his outstanding commitment to corporate social responsibility.

DSM scores highest in the Carbon Disclosure Project of the fifty largest companies listed at Euronext Amsterdam for its approach to climate change disclosure.

Q3 operating profit from continuing operations €139 million, more than double Q2 2009 (€58 million). Outlook for the rest of the year remains uncertain; Q4 operating profit currently expected to be lower than Q3, but above Q4 last year.

Award from PDMA recognizes DSM's strategic commitment to Open Innovation.

Joint ventures in China with NCPC suspended and DSM continues search for partners in China as the company prepares for further growth in the country.

Jan Zuidam, Deputy Chairman of the Managing Board of Directors of DSM, will retire on 1 January 2010.

Sale of DSM’s urea-licensing subsidiary Stamicarbon B.V. to Maire Tecnimont for a total consideration of €38 million on a cash and debt-free basis finalized.

Disposal consists of the participations which DSM has in oil and gas exploration and pipelines, including the 40% participation in Noordgastransport.

DSM updates investors and analysts at its annual Analysts Conference on the progress made with its Vision 2010 strategy and provides an update on recent trading conditions.

Anti-reflective coating system has contributed to achieving the highest energy conversion ever of a full-size solar module.

DSM regains number one position in the chemical industry sector in the Dow Jones Sustainability World Index.

Q2 operating profit from continuing operations clearly higher than Q1 2009. Cash flow from operating activities once again very strong (€267 million); 44% higher than Q2 2008. The outlook remains uncertain.

Comparative figures reflect reclassification of DSM Energy and Stamicarbon from the Base Chemicals & Materials cluster to discontinued operations and reclassification of DSM’s participation in Noordgastransport from Other activities to discontinued operations.

Agreement for sale of DSM’s urea-licensing subsidiary Stamicarbon B.V. to Maire Tecnimont for a total consideration of €38 million on a cash and debt-free basis reached.

Agreement with TAQA Abu Dhabi National Energy Company PJSC reached for sale of DSM Energie Holding B.V. (DSM Energy) for an enterprise value of €285 million.

DSM endorses strategy and pledges to continue to work in partnership with humanitarian organizations and governments to find sustainable solutions to the issue of micronutrient deficiency.

Acquisition of Biopract will serve as entry point for DSM into promising biogas market which is showing 15-20% growth per year.

Memorandum of understanding for DSM to acquire MCC’s Novamid® polyamide business in exchange for DSM’s Xantar® polycarbonate business.

Capacity for Stanyl® ForTii™ increased to meet market demand for this new polymer used in electronics and other applications.

Q1 operating profit down to €57 million. Continued strong cash performance, €166 million cash from operating activities. No quantitative outlook provided for 2009.

Comparative figures reflect reclassification of DSM Special Products from discontinued operations to continuing operations. DSM Special Products is now part of the Base Chemicals & Materials cluster.

DSM declares dividend for 2008 of €1.20 per ordinary share of €1.50 par value.

DSM held its Annual General Meeting of Shareholders on 25 March 2009. Shareholders approved all resolutions on the agenda.

Summary of the resolutions at DSM's Annual General Meeting of Shareholders 2009.

Contracts regarding investment by DSM in NCPC GroupCo and the establishment of three joint ventures in the areas of nutritional products and anti-infectives signed.

DSM presents its seventh annual sustainability report, the Triple P report (People, Planet, Profit) 2008.

Plant triples capacity for the production of Akulon® PA6, Arnite® PBT and PET and Stanyl® PA46 in India.

DSM successfully issues €500 million 5.75% bond due 2014.

Proposal to AGM to change Total Shareholder Return vesting scheme for stock options and performance shares (stock incentives) withdrawn.

DSM finds new way to resolve longstanding nutrition problem using its enzyme expertise to provide iron without increasing the risk of malaria.

Bio-based succinic acid demonstration plant in Lestrem (France) will be operational by the end of 2009.

Waterborne acrylic resins for use in coatings for joinery, decorative and industrial wood applications as well as in the graphic arts industry.

Standard & Poor’s confirmed its ‘A-‘ long-term and ‘A-2’ short term credit rating for DSM with a stable outlook. Moody’s confirmed its ‘A3’ long term and ‘P-2’ short term rating for the company, also with a stable outlook.

Full year operating profit up 10% to €903 million; Q4 down 35% to €123 million. Solid long-term financial position; dividend maintained at €1.20 per share.

Triple P report 2008 achieves an A+ according to the guidelines of the Global Reporting Initiative (GRI).

Twenty years ago DSM was first listed on Euronext Amsterdam.

Conditions EU Commission demanded leads to conclusion that intended sale no longer feasible.

DSM China Campus contains all DSM Shanghai offices, as well as several business groups and the DSM China R&D Centre. The Campus is DSM’s largest and most important research facility outside Europe and the USA, and is intended to act as an incubator for DSM’s local innovation competence.